Literature DB >> 3790407

The effect of age on theophylline clearance in normal subjects.

W C Randolph, J J Seaman, B Dickson, K E Peace, W O Frank, M D Young.   

Abstract

Dose-interval AUC and clearance of theophylline at steady-state were determined in healthy male subjects in each of three age groups (18-35, 36-54 and 55-70 years old). Mean AUC in the oldest group was significantly higher than in the youngest and clearance in both the middle and oldest groups was significantly lower than in the youngest. Though clearance was significantly correlated with age, age alone accounted for only 31% of the variability in clearance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790407      PMCID: PMC1401194          DOI: 10.1111/j.1365-2125.1986.tb02941.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Theophylline bioavailability following oral administration of six sustained-release preparations.

Authors:  D L Spangler; D D Kalof; F L Bloom; H J Wittig
Journal:  Ann Allergy       Date:  1978-01

2.  Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

Authors:  J R Powell; S Vozeh; P Hopewell; J Costello; L B Sheiner; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1978-08

3.  Aging, cigarette smoking and oral theophylline requirement.

Authors:  T Talseth; N P Boye; J Kongerud; J E Bredesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Theophylline kinetics in a geriatric group.

Authors:  R W Fox; S Samaan; S C Bukantz; R F Lockey
Journal:  Clin Pharmacol Ther       Date:  1983-07       Impact factor: 6.875

5.  Influence of age on theophylline clearance in patients with chronic obstructive pulmonary disease.

Authors:  L A Bauer; R A Blouin
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

6.  Theophylline kinetics in relation to age: the importance of smoking.

Authors:  B Cusack; J G Kelly; J Lavan; J Noel; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

7.  Theophylline kinetics in chronic obstructive airway disease in the elderly.

Authors:  W Y Au; A K Dutt; N DeSoyza
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

  7 in total
  2 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  The relationship between theophylline clearance and age in adult life.

Authors:  S H Jackson; A Johnston; R Woollard; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.